MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/rap/rkaf099

Медицинская библиотека · Rheumatology advances in practice · 2025

The IgA Vasculitis Study: the evolution of a cross-sectional cohort into a trial-ready cohort.

Williams Chloe E C, Marro Julien, Chetwynd Andrew J, Brown Joseph, Skoutelis Nikolaos, Dliso Silothabo, McBurney Catherine, Oni Louise

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

The aim of this report is to describe a single-centre cohort study and its evolutionary stages into a trial-ready cohort with the vision of stopping kidney failure secondary to IgA vasculitis (IgAV).

METHODS

The IgA Vasculitis Study was established as a single-centre, cross-sectional cohort study recruiting children with a clinical diagnosis of IgAV and has evolved into a trial-ready framework. Sociodemographic and clinical data, as well as corresponding biosamples, were collected longitudinally and the natural history of the first 100 recruits is provided.

RESULTS

The IgA Vasculitis Study commenced in June 2019. The first 100 children recruited to the study had a mean age of 7.3 years (s.d. 3.7) and a male:female ratio of 1.5:1. At presentation, all children had a lower limb-predominant rash, 76% had musculoskeletal involvement, 43% gastrointestinal involvement and 23% met the definition of nephritis. Most children (54%) were discharged after 6 months, however, 17% required paediatric nephrology input. The mean timing of onset for nephritis was 25.5 days (s.d. 22.9) following disease presentation (range 0.0-101 days). Fourteen children with IgAV nephritis (IgAV-N) received immunosuppression. Children with an older age, residing in more affluent areas, with gastrointestinal involvement or a positive urine dipstick (for proteinuria and/or haematuria) at presentation had greater odds of developing nephritis. Children with IgAV-N had statistically significantly more hospital visits and unplanned hospital admissions (P < 0.001).

CONCLUSION

Nephritis remains a serious consequence of IgAV with little evidence to guide management. This report outlines an exemplar study to advance the field towards better interventions.

Для цитирования: Williams Chloe E C, Marro Julien, Chetwynd Andrew J, Brown Joseph, Skoutelis Nikolaos, Dliso Silothabo, McBurney Catherine, Oni Louise. The IgA Vasculitis Study: the evolution of a cross-sectional cohort into a trial-ready cohort.. Rheumatology advances in practice. 2025. DOI: 10.1093/rap/rkaf099.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.